miR-144/451缺失通过刺激ULK1介导的游离α-珠蛋白自噬减轻β-地中海贫血
本文在β-地中海贫血中研究miR-144/451缺失如何通过两条机制减轻病理:miR-451缺失上调Cab39,增强LKB1-AMPK活性,抑制mTORC1并直接激活ULK1;同时miR-144/451缺失抑制成红细胞转铁蛋白受体1表达,造成细胞内铁限制。破坏Cab39或Ulk1基因可消除上述益处。
要点
- miR-451缺失上调Cab39,增强LKB1-AMPK活性,抑制mTORC1并激活ULK1。
- miR-144/451缺失抑制成红细胞转铁蛋白受体1表达,造成细胞内铁限制。
- 破坏Cab39或Ulk1基因可消除miR-144/451缺失对β-地中海贫血的有益效应。
核心结论
- 破坏双顺反子microRNA基因miR-144/451可通过降低mTORC1活性、经两条机制刺激ULK1介导的游离α-珠蛋白自噬而减轻β-地中海贫血。
- 作者认为β-地中海贫血的严重程度与高表达的成红细胞microRNA位点及一条可受治疗调控的代谢性蛋白质量控制通路相关。
研究设计与样本
- 基础研究:在β-地中海贫血模型中研究miR-144/451缺失的效应及其机制,并以破坏Cab39或Ulk1基因验证通路依赖性;原文未报告样本量。
主要发现
- miR-451缺失上调其靶信使RNA Cab39,Cab39编码LKB1的辅因子,LKB1可磷酸化并激活AMPK。
- LKB1活性增强后激活AMPK及其下游效应,包括抑制mTORC1和直接激活ULK1。
- miR-144/451缺失抑制成红细胞转铁蛋白受体1表达,导致细胞内铁限制;原文指出铁限制可抑制mTORC1、减少游离α-珠蛋白沉淀并改善β-地中海贫血的血液学指标。
- 破坏Cab39或Ulk1基因可抑制miR-144/451缺失在β-地中海贫血中的有益效应。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most cells can eliminate unstable or misfolded proteins through quality control mechanisms. In the inherited red blood cell disorder β-thalassemia, mutations in the β-globin gene (HBB) lead to a reduction in the corresponding protein and the accumulation of cytotoxic free α-globin, which causes maturation arrest and apoptosis of erythroid precursors and reductions in the lifespan of circulating red blood cells. We showed previously that excess α-globin is eliminated by Unc-51-like autophagy activating kinase 1 (ULK1)-dependent autophagy and that stimulating this pathway by systemic mammalian target of rapamycin complex 1 (mTORC1) inhibition alleviates β-thalassemia pathologies. We show here that disrupting the bicistronic microRNA gene miR-144/451 alleviates β-thalassemia by reducing mTORC1 activity and stimulating ULK1-mediated autophagy of free α-globin through 2 mechanisms. Loss of miR-451 upregulated its target messenger RNA, Cab39, which encodes a cofactor for LKB1, a serine-threonine kinase that phosphorylates and activates the central metabolic sensor adenosine monophosphate-activated protein kinase (AMPK). The resultant enhancement of LKB1 activity stimulated AMPK and its downstream effects, including repression of mTORC1 and direct activation of ULK1. In addition, loss of miR-144/451 inhibited the expression of erythroblast transferrin receptor 1, causing intracellular iron restriction, which has been shown to inhibit mTORC1, reduce free α-globin precipitates, and improve hematological indices in β-thalassemia. The beneficial effects of miR-144/451 loss in β-thalassemia were inhibited by the disruption of Cab39 or Ulk1 genes. Together, our findings link the severity of β-thalassemia to a highly expressed erythroid microRNA locus and a fundamental, metabolically regulated protein quality control pathway that is amenable to therapeutic manipulation.
引用
- Keith J, Christakopoulos GE, Fernandez AG, et al. Loss of miR-144/451 alleviates β-thalassemia by stimulating ULK1-mediated autophagy of free α-globin. Blood. 2023. PMID: 37339583. doi:10.1182/blood.2022017265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。